Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir/Ritonavir 200/100 mg vs 300/100 mg in HIV Patients
NCT00411957Phase 2Completed
- Sponsor
- HIV-NAT
- Start
- Jan 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Started Jan 2007; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00411957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411957.